thyssenkrupp nucera KGaA Second Quarter 2025 Earnings: €0.03 loss per share (vs €0.057 loss in 2Q 2024)

In This Article:

thyssenkrupp nucera KGaA (ETR:NCH2) Second Quarter 2025 Results

Key Financial Results

  • Revenue: €216.0m (up 29% from 2Q 2024).

  • Net loss: €3.00m (loss narrowed by 58% from 2Q 2024).

  • €0.03 loss per share (improved from €0.057 loss in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth
XTRA:NCH2 Earnings and Revenue Growth May 20th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

thyssenkrupp nucera KGaA Earnings Insights

Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Construction industry in Europe.

Performance of the market in Germany.

The company's shares are down 12% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for thyssenkrupp nucera KGaA you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.